CalciMedica, Inc. (CALC)
2025-06-30 | ||||
|---|---|---|---|---|
| Research and development | 4,052 | |||
| General and administrative | 2,569 | |||
| Total operating expenses | 6,621 | |||
| Loss from operations | -6,621 | |||
| Net loss | -6,000 | |||
| Earnings per share, basic, total | -0.4 | |||
| Earnings per share, diluted, total | -0.4 | |||
| Weighted-average number of shares outstanding used in computing net loss per share - basic | 14,995,404 | |||
| Weighted-average number of shares outstanding used in computing net loss per share - diluted | 14,995,404 | |||